Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that a better understanding of cell changes during wound healing could improve treatments for chronic wounds and other conditions.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

TGF-β signaling is crucial for stem cell maintenance, differentiation, and has implications for cancer treatment.

Different types of stem cells exist within individual skin layers, and they can adapt to damage, transplantation, or tumor growth. These cells are regulated by their environment and genetic factors. Tumor growth is driven by expanding, genetically altered cells, not long-lived mutant stem cells. There's evidence of cancer stem cells in skin tumors. Other cells, bacteria, and genetic factors help maintain balance and contribute to disease progression. A method for growing mini organs from single cells has been developed.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

UV radiation can help sterilize wounds and promote healing but requires careful use to avoid damaging cells.

The Wnt/β-catenin pathway is important for tissue development and has potential in regenerative medicine, but requires more research for therapeutic use.

Epidermal stem cells could lead to new treatments for skin and hair disorders.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

New mutations in hair keratin genes cause the rare hair disorder monilethrix.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Using polyethylenimine-DNA to deliver the hTERT gene can stimulate hair growth and may be useful in treating hair loss, but there could be potential cancer risks.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Preventing and managing skin issues from cancer treatment is crucial, especially in high UV areas like Australia and New Zealand.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Men are more likely to have larger basal cell carcinomas and squamous cell carcinomas, while women have more superficial basal cell carcinomas and tumors on their legs and central face.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Natural products may help treat Non-Small Cell Lung Cancer by causing cancer cell death through ferroptosis.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Vav2 and Vav3 proteins help control skin stem cell numbers and activity in both healthy and cancerous cells.

The research created a detailed map of skin cells, showing that certain cells in basal cell carcinoma may come from hair follicles and could help the cancer grow.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Reporter characteristics affect detection of hair loss from cancer therapy.